Rimma Shaposhnikov, MD UCLA gastroenterologist and Natalie Manitius, MPH, RDN, UCLA GI Dietitian, discuss which screening modalities work for colon cancer, how often one needs to get screened when a person can stop colonoscopies and dietary tips to prevent colon cancer.
Dr. Gonzalo Sapisochin presents his research using living liver transplantation as a treatment for patients with colorectal cancer that has spread to the liver. Liver transplantation is frequently used as a curative treatment for selected patients with the most common liver cancer, hepatocellular carcinoma. Dr. Sapisochin’s study is expanding liver transplantation to patients with colorectal cancer which has spread to the liver. Colorectal cancer is diagnosed in 1.8 million people every year and it is estimated that in approximately 50 percent of these cases, cancer will spread to the liver. "We think that pre-transplant chemotherapy, careful monitoring of tumors, and living donation will give our patients better results," says Dr. Sapisochin.
Sasikumar Kilaikode et.al. presented a talk on Neuromuscular Disorders in children with a perspective of Pulmonology with an objective to discuss respiratory patholophysilogy of neuromuscular disease in children, outlining the monitoring of pulmonary features and discussing the management of chronic respiratory failure in children with neuro-muscular disorders in children.
In this video Houston Methodist Hospital, Dipan J. Shah, MD, interviews Paul M. Ridker, MD discussing his Grand Rounds Conference about "Inflammation and Atherosclerosis: Where have we been? Where are we going?" This talk was presented by Houston Methodist DeBakey Heart & Vascular Center.
Kamal Bhsual presented a talk on Primary Hyperparathyroidism with an objective of understanding the etiology, pathophysiology, manifestations, investigations and the management. The speaker has also discussed about the cases of Normocalcemic Primary Hyperparathyroidism and the points to consider under such instances.
Dr. Patrick Kamath presented a talk on liver in cases of Cardiac diseases. The speaker has discussed in detail about its symptomatolgy, progression of symptoms, identification of diagnostic signs, recommended investigations and lastly current updates in the treatment strategies of the same.
Ashley E. Ross, MD, PhD, Executive Medical Director of the Mary Crowley Cancer Research Center in Dallas, discusses the current and potential impact of PSMA PET imaging on the identification and treatment of localized prostate cancer. He notes how PET PSMA and fluciclovine imaging can increase the accuracy of detecting clinically significant localized disease. Dr. Ross further discusses how PET imaging assists in risk stratification of candidates for treatment of HSPC, nmCRPC using salvage local therapy, metastasis-directed therapy, or intensification of systemic therapy. He also discusses how PET imaging can help identify candidates for cure with local treatments.
Dr. Chi kicks off his multi-part Scan Solutions series by reviewing the initial evaluation scan in order to determine if the scan is ready to be submitted.
Michael J. Zelefsky, MD, discusses the need for advances in molecular imaging and radionics and for integrating these techniques with precision radiation therapy in order to improve selective dose delivery for low- and intermediate-risk prostate cancer patients. He describes evolving methods of radiation delivery, dose planning, reducing radiation exposure to normal tissues, and delineation of the dominant intraprostatic lesion in this era of dose-escalation.
Brittany D. Chambers, PhD, MPH, discusses the relationship between racism and infant/adolescent health outcomes, and describes policy recommendations to improve educational opportunities and economic growth in black communities.